| scholarly article | Q13442814 |
| P50 | author | Michael Karin | Q1458081 |
| Mark A Valasek | Q59557458 | ||
| Hayato Nakagawa | Q80174875 | ||
| P2093 | author name string | Michael N Hall | |
| Ekihiro Seki | |||
| Koji Taniguchi | |||
| Jun Hee Lee | |||
| Atsushi Umemura | |||
| Mariam Aghajan | |||
| Eek Joong Park | |||
| Shabnam Shalapour | |||
| P2860 | cites work | Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity | Q24598427 |
| mTOR is a key modulator of ageing and age-related disease | Q24610741 | ||
| Rapamycin fed late in life extends lifespan in genetically heterogeneous mice | Q24647805 | ||
| Targeting the mTOR pathway in hepatocellular carcinoma: current state and future trends | Q26830194 | ||
| TOR signaling in growth and metabolism | Q27860757 | ||
| Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults | Q28131763 | ||
| Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle | Q28140704 | ||
| Defining the role of mTOR in cancer | Q28235431 | ||
| Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in Yeast | Q28277565 | ||
| Profiling sirolimus-induced inflammatory syndrome: a prospective tricentric observational study | Q28484885 | ||
| Autophagy regulates lipid metabolism | Q29547421 | ||
| Ras, PI(3)K and mTOR signalling controls tumour cell growth | Q29614734 | ||
| Activation of a metabolic gene regulatory network downstream of mTOR complex 1 | Q29615179 | ||
| Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression | Q29615766 | ||
| mTOR and cancer: insights into a complex relationship | Q29617779 | ||
| Rapamycin extends murine lifespan but has limited effects on aging | Q30541884 | ||
| The yeast Tor signaling pathway is involved in G2/M transition via polo-kinase | Q33336423 | ||
| Raptor is phosphorylated by cdc2 during mitosis | Q33532654 | ||
| Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling | Q33588191 | ||
| Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation | Q33737707 | ||
| Sustained activation of mTORC1 in skeletal muscle inhibits constitutive and starvation-induced autophagy and causes a severe, late-onset myopathy | Q34340407 | ||
| Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy | Q34891582 | ||
| S6 kinase 1 is required for rapamycin-sensitive liver proliferation after mouse hepatectomy. | Q35572388 | ||
| High-dose rapamycin induces apoptosis in human cancer cells by dissociating mTOR complex 1 and suppressing phosphorylation of 4E-BP1. | Q35694634 | ||
| Phase 1/2 study of everolimus in advanced hepatocellular carcinoma | Q36160273 | ||
| Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations | Q36742629 | ||
| The mammalian target of rapamycin signaling pathway: twists and turns in the road to cancer therapy | Q36838789 | ||
| Targeting the mTOR signaling network in cancer. | Q36955694 | ||
| Chronic activation of mTOR complex 1 is sufficient to cause hepatocellular carcinoma in mice. | Q37094456 | ||
| Common corruption of the mTOR signaling network in human tumors | Q37643431 | ||
| Evolving strategies for the treatment of hepatocellular carcinoma: from clinical-guided to molecularly-tailored therapeutic options. | Q37783666 | ||
| Rapamycin passes the torch: a new generation of mTOR inhibitors | Q37950771 | ||
| mTOR in aging, metabolism, and cancer | Q38073906 | ||
| The mTOR pathway in hepatic malignancies | Q38081396 | ||
| Evidence for rapamycin toxicity in pancreatic β-cells and a review of the underlying molecular mechanisms. | Q38123696 | ||
| Review of combination therapy with mTOR inhibitors and tacrolimus minimization after transplantation | Q38127967 | ||
| Therapeutic potential and adverse events of everolimus for treatment of hepatocellular carcinoma - systematic review and meta-analysis | Q38176862 | ||
| Mitotic raptor promotes mTORC1 activity, G(2)/M cell cycle progression, and internal ribosome entry site-mediated mRNA translation | Q39707997 | ||
| 47 Liver cells | Q41460095 | ||
| Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma | Q43049041 | ||
| AMPKα1 controls hepatocyte proliferation independently of energy balance by regulating Cyclin A2 expression | Q44009527 | ||
| Rapamycin unbalances the polarization of human macrophages to M1. | Q45057583 | ||
| The TSC-mTOR signaling pathway regulates the innate inflammatory response | Q46321173 | ||
| IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis | Q46576855 | ||
| Reducing the load: the evolution and management of obesity and nonalcoholic steatohepatitis before liver transplantation | Q48232083 | ||
| Evaluation of rapamycin-induced cell death. | Q54546876 | ||
| The use of sirolimus should be restricted in liver transplantation | Q84529512 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 133-144 | |
| P577 | publication date | 2014-06-05 | |
| P1433 | published in | Cell Metabolism | Q1254684 |
| P1476 | title | Liver damage, inflammation, and enhanced tumorigenesis after persistent mTORC1 inhibition | |
| P478 | volume | 20 |
| Q34465259 | A gp130-Src-YAP module links inflammation to epithelial regeneration |
| Q45074792 | A population of innate myelolymphoblastoid effector cell expanded by inactivation of mTOR complex 1 in mice. |
| Q52914745 | Amino Acid-Induced Activation of mTORC1 in Rat Liver Is Attenuated by Short-Term Consumption of a High-Fat Diet. |
| Q40073257 | An epigenome-wide association study of inflammatory response to fenofibrate in the Genetics of Lipid Lowering Drugs and Diet Network |
| Q59791348 | An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma |
| Q53687520 | Baicalein targets GTPase-mediated autophagy to eliminate liver tumor initiating stem cell-like cells resistant to mTORC1 inhibition. |
| Q33566874 | Branched-chain amino acids prevent hepatic fibrosis and development of hepatocellular carcinoma in a non-alcoholic steatohepatitis mouse model |
| Q37612521 | Chronic innate immune activation of TBK1 suppresses mTORC1 activity and dysregulates cellular metabolism |
| Q37438972 | Circulating periostin in relation to insulin resistance and nonalcoholic fatty liver disease among overweight and obese subjects |
| Q45965446 | Clinical and genetic characterisation of infantile liver failure syndrome type 1, due to recessive mutations in LARS. |
| Q99708210 | Comprehensive Assessment of Side Effects in COVID-19 Drug Pipeline from a Network Perspective |
| Q91387626 | Concurrent activation of growth factor and nutrient arms of mTORC1 induces oxidative liver injury |
| Q52536411 | DNA methylation as a marker of response in rheumatoid arthritis. |
| Q92838962 | Decreased cytoplasmic expression of Raptor correlates with disease progression and unfavorable prognosis in hepatocellular carcinoma |
| Q94503651 | Defects in mTORC1 Network and mTORC1-STAT3 Pathway Crosstalk Contributes to Non-inflammatory Hepatocellular Carcinoma |
| Q46300688 | Dietary alterations modulate susceptibility to Plasmodium infection |
| Q55352012 | Dietary patterns and primary liver cancer in Chinese adults: a case-control study. |
| Q34452213 | Divergent tissue and sex effects of rapamycin on the proteasome-chaperone network of old mice. |
| Q34500113 | Drugs acting on homeostasis: challenging cancer cell adaptation |
| Q92076117 | Dual Roles of Mammalian Target of Rapamycin in Regulating Liver Injury and Tumorigenesis in Autophagy-Defective Mouse Liver |
| Q90466739 | Dynamic MTORC1-TFEB feedback signaling regulates hepatic autophagy, steatosis and liver injury in long-term nutrient oversupply |
| Q34499441 | Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma |
| Q26764911 | Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play |
| Q26772317 | Hepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genes |
| Q42036894 | Hepatocyte nuclear factor 1α suppresses steatosis-associated liver cancer by inhibiting PPARγ transcription |
| Q40548325 | Identification of expression quantitative trait loci of RPTOR for susceptibility to glioma |
| Q35554147 | Livers with constitutive mTORC1 activity resist steatosis independent of feedback suppression of Akt. |
| Q54976725 | Metastasis-associated lung adenocarcinoma transcript 1 as a common molecular driver in the pathogenesis of nonalcoholic steatohepatitis and chronic immune-mediated liver damage. |
| Q41335354 | MicroRNA-148a deficiency promotes hepatic lipid metabolism and hepatocarcinogenesis in mice |
| Q36751634 | Multiple amino acid sensing inputs to mTORC1. |
| Q36288405 | New Approaches for Studying Alcoholic Liver Disease |
| Q38705659 | Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies |
| Q50249485 | Nonalcoholic fatty liver disease promotes hepatocellular carcinoma through direct and indirect effects on hepatocytes |
| Q92377542 | Obesity and diabetes accelerate hepatocarcinogenesis via hepatocyte proliferation independent of NF-κB or Akt/mTORC1 |
| Q36719439 | Prohibitin-induced, obesity-associated insulin resistance and accompanying low-grade inflammation causes NASH and HCC |
| Q37000451 | Rapamycin Increases Mortality in db/db Mice, a Mouse Model of Type 2 Diabetes |
| Q58795433 | Rapamycin Upregulates Connective Tissue Growth Factor Expression in Hepatic Progenitor Cells Through TGF-β-Smad2 Dependent Signaling |
| Q33804727 | Raptor regulates functional maturation of murine beta cells. |
| Q41921861 | Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine |
| Q47605867 | Silibinin Reduces the Impact of Obesity on Invasive Liver Cancer |
| Q46672733 | Soyabean glycinin depresses intestinal growth and function in juvenile Jian carp (Cyprinus carpio var Jian): protective effects of glutamine |
| Q37038522 | Spontaneous Hepatocellular Carcinoma after the Combined Deletion of Akt Isoforms. |
| Q28834275 | Stat3 is a candidate epigenetic biomarker of perinatal Bisphenol A exposure associated with murine hepatic tumors with implications for human health |
| Q91962615 | The Upstream Pathway of mTOR-Mediated Autophagy in Liver Diseases |
| Q49960374 | Time-resolved analysis of amino acid stress identifies eIF2 phosphorylation as necessary to inhibit mTORC1 activity in liver. |
| Q53126851 | [Clinical feature and molecular diagnostic analysis of the first non-caucasian child with infantile liver failure syndrome type 1]. |
| Q52319565 | mTOR at the Transmitting and Receiving Ends in Tumor Immunity. |
| Q38590634 | mTOR in health and in sickness |
| Q47352692 | mTORC1 suppresses PIM3 expression via miR-33 encoded by the SREBP loci. |
| Q38987558 | p62 in Cancer: Signaling Adaptor Beyond Autophagy |
| Q42716243 | p62, Upregulated during Preneoplasia, Induces Hepatocellular Carcinogenesis by Maintaining Survival of Stressed HCC-Initiating Cells |
| Q38893853 | p62/SQSTM1-Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer |
Search more.